Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Clonmel Healthcare’s Uzpruvo▼ (Ustekinumab) is recommended as a Best Value Biologic

Summary by Irish Medical Times
Effective from June 1, 2026 Uzpruvo® is recommended as a Best Value Biologic for Ustekinumab on the High Tech Arrangement1
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

Irish Medical TimesIrish Medical Times

Clonmel Healthcare’s Uzpruvo▼ (Ustekinumab) is recommended as a Best Value Biologic

Effective from June 1, 2026 Uzpruvo® is recommended as a Best Value Biologic for Ustekinumab on the High Tech Arrangement1

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Irish Medical Times broke the news on Tuesday, September 1, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Clonmel icon

Clonmel

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal